Affordable Access

Publisher Website

Transcriptome analysis of a tau overexpression model in rats implicates an early pro-inflammatory response

Experimental Neurology
Publication Date
DOI: 10.1016/j.expneurol.2010.03.011
  • Adeno-Associated Virus
  • Neurodegenerative Diseases
  • Microarray
  • Microtubule-Associated Protein Tau
  • Gene Transfer
  • Immune Response
  • Gliosis
  • Progressive Supranuclear Palsy
  • Biology
  • Medicine


Abstract Neurofibrillary tangles comprised of the microtubule-associated protein tau are pathological features of Alzheimer's disease and several other neurodegenerative diseases, such as progressive supranuclear palsy. We previously overexpressed tau in the substantia nigra of rats and mimicked some of the neurodegenerative sequelae that occur in humans such as tangle formation, loss of dopamine neurons, and microgliosis. To study molecular changes involved in the tau-induced disease state, we used DNA microarrays at an early stage of the disease process. A range of adeno-associated virus (AAV9) vector doses for tau were injected in groups of rats with a survival interval of 2 weeks. Specific decreases in messages for dopamine-related genes validated the technique with respect to the dopaminergic cell loss observed. Of the mRNAs upregulated, there was a dose-dependent effect on multiple genes involved in immune response such as chemokines, interferon-inducible genes and leukocyte markers, only in the tau vector groups and not in dose-matched controls of either transgene-less empty vector or control green fluorescent protein vector. Histological staining for dopamine neurons and microglia matched the loss of dopaminergic markers and upregulation of immune response mRNAs in the microarray data, respectively. RT-PCR for selected markers confirmed the microarray results, with similar changes found by either technique. The mRNA data correlate well with previous findings, and underscore microgliosis and immune response in the degenerative process following tau overexpression.

There are no comments yet on this publication. Be the first to share your thoughts.